Business Context and Reporting Period
This Form 8-K filing by Alnylam Pharmaceuticals, Inc. reports on events occurring on March 22, 2012, with the report filed on March 28, 2012. The filing details the approval of the 2012 Annual Incentive Program by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structure of the 2012 employee compensation plan.
Material Changes
The primary material change reported is the establishment of the 2012 Annual Incentive Program. Key structural elements include:
- Eligibility: All regular employees, including executive officers.
- Performance Threshold: No bonus awards will be paid if the Corporate Performance Level falls below 50%.
- Payout Cap: Bonus awards are capped at 100% of a participant's Target Award.
- Target Awards (% of Base Salary):
- Chief Executive Officer: 60%
- President and Chief Operating Officer: 50%
- Senior Vice President: 40%
- Vice President: 30%
- Senior Director/Director: 20%
- Associate Director: 15%
- All Other Regular Employees: 7.5%
Guidance, Outlook, and Management Commentary
Management commentary is limited to the mechanics of the incentive plan. The Committee will evaluate corporate and individual performance in December 2012 to establish the Bonus Pool. Any approved Bonus Awards are expected to be paid in January 2013. The Committee retains discretion to adjust awards or the pool upward or downward.
Investor Verification Checklist
- Verify the specific corporate goals established for 2012 to assess the likelihood of meeting the 50% performance threshold.
- Review the company's cash position to ensure liquidity is sufficient to cover potential bonus payouts in January 2013.
- Confirm if the 2012 corporate goals were subsequently met or if the plan was modified in later filings.
- Check subsequent 10-K or 10-Q filings for the actual bonus expense recognized for the 2012 fiscal year.